correctionAn earlier version of this column misidentified Altria Group as the purchaser of an inhaler device manufacturer. Philip Morris International purchased the inhaler device company. This ...
Asthma Drug Albuterol Shortage Is About To Worsen: Here’s Why—And How Hospitals Are Filling The Gaps
Several major manufacturing plants for the asthma and respiratory drug Albuterol have shut down, possibly worsening an already-flaring shortage of the medication that has forced hospitals to devise ...
During an asthma check-up at Brigham and Women's Hospital in Boston, Joel Rubinstein gets a surprising pitch — for the planet, as well as his health. His pulmonologist, Dr. Miguel Divo, explains that ...
There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy for chronic obstructive pulmonary disease (COPD), according to real-world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results